EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Greenbrook TMS's enterprise value is C$186.1 Mil.
Greenbrook TMS's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$-54.4 Mil. Therefore, Greenbrook TMS's EV-to-EBITDA for today is -3.42.
The historical rank and industry rank for Greenbrook TMS's EV-to-EBITDA or its related term are showing as below:
TSX:GTMS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -30.03 Med: -7.34 Max: -0.05
Current: -2.75
During the past 8 years, the highest EV-to-EBITDA of Greenbrook TMS was -0.05. The lowest was -30.03. And the median was -7.34.
TSX:GTMS's EV-to-EBITDA is ranked worse than 100% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.19
vs TSX:GTMS: -2.75
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-24), Greenbrook TMS's stock price is C$1.15.
Greenbrook TMS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.000. Therefore, Greenbrook TMS's PE Ratio for today is N/A.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Greenbrook TMS EV-to-EBITDA Historical Data
The historical data trend for Greenbrook TMS's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Greenbrook TMS's EV-to-EBITDA
For the Medical Care Facilities subindustry, Greenbrook TMS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenbrook TMS's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Greenbrook TMS's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Greenbrook TMS's EV-to-EBITDA falls into.
Greenbrook TMS EV-to-EBITDA Calculation
Greenbrook TMS's EV-to-EBITDA for today is calculated as:
Greenbrook TMS's current Enterprise Value is C$186.1 Mil.
Greenbrook TMS's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-54.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Greenbrook TMS's PE Ratio for today is calculated as:
Greenbrook TMS's share price for today is C$1.15.
Greenbrook TMS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Greenbrook TMS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:GTMS has been successfully added to your 